Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Strict Versus Permissive Threshold for Initiation of Pharmacotherapy in Gestational Diabetes Mellitus (GDM) With Continuous Glucose Monitoring Use - A Randomized Control Trial (START 2 Trial)

NCT06419803 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT06419803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06419803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Strict Versus Permissive Threshold for Initiation of Pharmacotherapy in Gestational Diabetes Mellitus (GDM) With Continuous Glucose Monitoring Use - A Randomized Control Trial (START 2 Trial)
Lead sponsor
Thomas Jefferson University
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2024
Completion date
May 31, 2026
Enrollment
430 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes, pregnancy related